Drug-target networks in aminoglycoside resistance: Hierarchy of priority in structural drug design

MedChemComm

Volumn 7, Issue 1, 2016, Pages 103-113

  Bacot Davis, Valjean R ^a,b   Bassenden, Angelia V ^a,b   Berghuis, Albert M ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b Groupes de Recherche GRASP et PROTEO   (Canada)

^c Bellini Pavilion   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; NUCLEOTIDYLTRANSFERASE; PAROMOMYCIN; PHOSPHOTRANSFERASE; PLAZOMICIN; SPECTINOMYCIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BINDING AFFINITY; DEACETYLATION; DRUG BINDING; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE COMPLEX; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; MEMBRANE TRANSPORT; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; RNA BINDING;

EID: 84955323086     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c5md00384a     Document Type: Review

References (104)

1. D. R. Riley K. B. Sieber K. M. Robinson J. R. White A. Ganesan S. Nourbakhsh et al., Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples PLoS Comput. Biol. 2013 9 6 e1003107
2. J. T. Stock, Are human still evolving? Technological advances and unique biological characteristics allow us to adapt to environmental stress. Has this stopped genetic evolution?, EMBO Rep. Georg von Holtzbrinck Publishing Group, 2008, vol. 9 (Suppl 1), pp. S52-S54
3. E. V. Hulse Leprosy and ancient Egypt Lancet 1972 2 7785 1024 1025
4. M. Schultz Paleohistopathology of bone: a new approach to the study of ancient diseases Am. J. Phys. Anthropol. 2001 Suppl 33 106 147
5. S. J. Olshansky B. Cernes R. G. Rogers L. Smith Infectious disases - new and ancient threats to world health Popul Bull. 1997 52 2 1 52
6. G. M. Baer Rabies - an historical perspective Infect. Agents Dis. 1994 3 4 168 180
7. Boundless. History of Bacterial Diseases [Internet]. Boundless Biology. 2015 [cited 2015 Aug 30]. Available from: https://www.boundless.com/biology/textbooks/boundless-biology-textbook/prokaryotes-bacteria-and-archaea-22/bacterial-diseases-in-humans-143/history-of-bacterial-diseases-566-11779/
8. B. Spellberg R. Guidos D. Gilbert J. Bradley H. W. Boucher W. Michael Scheld et al., The epidemic of antibiotic-resistance infections: a call to action for the medical community from the infectious diseases society of america Clin. Infect. Dis. 2008 46 2 155 164
9. M. Bonafede LB Rice LB. Emerging antibiotic resistance J. Lab. Clin. Med. 1997 130 6 558 566
10. A. Demirjian G. V. Sanchez J. A. Finkelstein S. M. Ling L. A. Pollack L. A. Hicks et al., CDC grand rounds: getting smart about antibiotics MMWR Morb. Mortal. Wkly. Rep. 2015 64 32 871 873
11. J. O'Neill, Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. [Internet]. London, UK; 2014. Available from: http://amr-review.org/sites/default/files/AMR Review Paper-Tackling a crisis for the health and wealth of nations-1.pdf
12. H. W. Boucher G. H. Talbot D. K. J. Benjamin J. Bradley R. J. Guidos R. N. Jones et al., 10 × '20 Progress - development of new drugs active against Gram-negative bacilli: an update from the Infectious Diseases Society of America Clin. Infect. Dis. 2013 56 12 1685 1694
13. Organization WH, Antimicrobial resistance: global report on surveillance [Internet]. 2014. Available from: http://www.who.int/drugresistance/documents/surveillancereport/en
14. A. R. M. Coates G. Halls Y. Hu Novel classes of antibiotics or more of the same? Br. J. Pharmacol. 2011 162 1 184 194
15. R. W. Finberg R. C. Moellering F. P. Tally W. A. Craig G. A. Pankey E. P. Dellinger et al., The importance of bactericidal drugs: future directions in infectious disease Clin. Infect. Dis. 2004 39 9 1314 1320
16. J. Davies L. Gorini B. D. Davis Misreading of RNA codewords induced by aminoglycoside antibiotics Mol. Pharmacol. 1965 1 93 106
17. M. A. Borovinskaya R. D. Pai W. Zhang B. S. Schuwirth J. M. Holton G. Hirokawa et al., Structural basis for aminoglycoside inhibition of bacterial ribosome recycling Nat. Struct. Mol. Biol. 2007 14 8 727 732
18. D. S. Pilch M. Kaul C. M. Barbieri J. E. Kerrigan Thermodynamics of aminoglycoside r-RNA recognition Biopolymers 2003 70 1 58 79
19. M. Chittapragada S. Roberts Y. W. Ham Aminoglycosides: molecular insights on the recognition of RNA and aminoglycoside mimics Perspect. Med. Chem. 2009 3 21 37
20. M.-P. Mingeot-Leclercq Y. Glupczynski P. M. Tulkens Aminoglycosides: activity and resistance Antimicrob. Agents Chemother. 1999 43 4 727 737
21. M. Tsukamura A preliminary trial of lividomycin in patients with pulmonary tuberculosis Tubercle 1972 53 1 43 46
22. F. Kobayashi M. Yamaguchi S. Mitsuhashi Activity of Lividomycin Against Pseudomonas aeruginosa: Its Inactivation by Phosphorylation Induced by Resistant Strains Antimicrob. Agents Chemother. 1972 1 17 21
23. A. Leroy G. Humbert G. Oksenhendler J. P. Fillastre Comparative pharmacokinetic of lividomycin, amikacin and sisomicin in normal subjects and in uraemic patients J. Antimicrob. Chemother. 1976 2 373
24. Organization WH, Critically important antimicrobials for human medicine, (3rd revision), 2011
25. N. P. Kurumbang K. Liou J. K. Shong Biosynthesis of Ribostamycin Derivatives by Reconstitution and Heterologous Expression of Required Gene Sets Appl. Biochem. Biotechnol. 2011 163 373 382
26. A. Prayle A. R. Smyth Aminoglycoside use in cystic fibrosis: therapeutic strategies and toxicity Curr. Opin. Pulm. Med. 2010 16 604 610
27. K. Shi S. J. Caldwell D. H. Fong A. M. Berghuis Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance Front. Cell. Infect. Microbiol. 2013 3 22 10.3389/fcimb.2013.00022
28. K. Deguchi M. Kogushi Y. Suzuki S. Tanaka S. Fukayama R. Ishihara et al., Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 1. Activities against Staphylococcus aureus Jpn. J. Antibiot. 1996 49 2 194 202
29. S. Aonuma F. Ariji K. Oizumi K. Konno Electron microscopy of Pseudomoas aeruginosa treated with sulbenicillin and dibekacin Tohoku J. Exp. Med. 1987 152 2 119 128
30. A. Santé française de sécurité sanitaire des produits de. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmicin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring Med. Mal. Infect 2012 42 7 301 308
31. T. A. Rodriquez Sisomicin sulfate: its efficacy in the treatment of urologic infections Arch. Esp. Urol. 1979 32 4 387 396
32. A. Zumla P. Nahid S. T. Cole Advances in the development of new tuberculosis drugs and treatment regimens Nat. Rev. Drug Discovery 2013 12 388 404
33. S. Shakil R. Khan R. Zarrilli A. U. Khan Aminoglycosides versus bacteria - a description of the action, resistance mechanism, and nosocomial battleground J. Biomed. Sci. 2008 15 1 5 14
34. S. Jana J. K. Deb Molecular understanding of aminoglycoside action and resistance Appl. Microbiol. Biotechnol. 2006 70 2 140 150
35. H. I. Zgurskaya J. W. Weeks A. T. Ntreh L. M. Nickels D. Wolloscheck Mechanism of coupling drug transport reactions located in two different membranes Front Microbiol. 2015 6 100
36. M. S. Ramirez M. E. Tolmasky Aminoglycoside modifying enzymes Drug Resist. Updates 2010 13 151 171
37. J. Romanowska J. A. McCammon J. Rylska Understanding the origins of bacterial resistance to aminoglycosides through molecular dynamics mutational study of the ribosomal A-site PLoS Comput. Biol. 2011 7 7 e1002099
38. D. L. Mayers, Antimicrobial Drug Resistance: Mechanisms of Drug Resistance, 1st ed. ed., D. L. Mayers, S. A. Lerner, M. Ouellette, and, J. D. Sobel, Humana Press, Springer Science+Business Media, LLC, New York, NY, 2009, pp. 89-91
39. G. F. Liou S. Yoshizama P. Courvalin M. Galimand Aminoglycoside resistance by ArmA-mediated ribosomal 16S methylation in human bacterial pathogens J. Mol. Biol. 2006 359 2 358 364
40. J. A. Dunkle K. Vinal P. M. Desai N. Zelinskaya M. Savic D. M. West et al., Molecular recognition and modification of the 30S ribosome by the aminoglycoside-resistance methyltransferase NpmA Proc. Natl. Acad. Sci. U. S. A. 2014 111 17 6275 6280
41. L. Hidalgo K. L. Hopkins B. Gutierrez C. M. Ovejero S. Shukla S. Douthwaite et al., Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK J. Antimicrob. Chemother. 2013 68 7 1543 1550
42. C. S. Lee S. Vasoo F. Hu R. Patel Y. Doi Klebsiella pneumoniae ST147 Coproducing NDM-7 Carbapenemase and RmtF 16S rRNA Methyltransferase in Minnesota J. Clin. Microbiol. 2014 52 11 4109 4110
43. R. J. Fair Y. Tor Antibiotics and Bacterial Resistance in the 21st Century Perspect. Med. Chem. 2014 6 25 64
44. M. Galimand P. Courvalin T. Lambert RmtF, a new member of the aminoglycoside resistance 16S rRNA N7 G1405 methyltransferase family Antimicrob. Agents Chemother. 2012 56 7 3960 3962
45. Y. Samadi I. Pakzad A. Monadi Sefidan H. Hosainzadegan A. Tanomand Study of aminoglycoside resistance genes in enterococcus and salmonella strains isolated from ilam and milad hospitals, iran. Jundishapur J. Microbiol 2015 8 4 e18102
46. E. Y. Rosenberg D. Ma H. Nikaido AcrD of Escherichia coli is an aminoglycoside efflux pump J. Bacteriol. 2000 182 6 1754 1756
47. Secret Agents: The Menace of Emerging Infections. Revised ed. Books P, ed., M. Drexler, New York, NY, 2009
48. S. Magnet P. Courvalin T. Lambert Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454 Antimicrob. Agents Chemother. 2001 45 12 3375 3380
49. L. E. Bryan S. Kwan Mechanisms of aminoglycoside resistance of anaerobic bacteria and facultative bacteria grown anaerobically J. Antimicrob. Chemother. 1981 8 Suppl 500 1 8
50. F. Vaziri S. N. Peerayeh Q. B. Nejad A. Farhadian The prevalence of aminoglycoside-modifying enzyme genes (aac (6′)-I, aac (6′)-II, ant (2′′)-I, aph (3′)-VI) in Pseudomonas aeruginosa Clinics 2011 66 9 1519 1522
51. K. J. Shaw P. N. Rather R. S. Hare G. H. Miller Molecular genetic of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes Microbiol. Rev. 1993 57 138 163
52. G. H. Miller F. J. Sabatelli R. S. Hare Y. Glupczynski P. Mackey D. Shlaes The most frequent aminoglycoside resistance mechanisms-changes with time and geographic area: a reflection of aminoglycoside usage patterns? Clin. Infect. Dis. 1997 24 Suppl 1 S46 62
53. E. Wolf A. Vassilev Y. Makino A. Sali Y. Nakatani S. K. Burley Crystal structuer of a GCN5-related N-acetyltransferase: Serratia marcescens aminoglycoside 3-N-acetyltransferase Cell 1998 94 439 449
54. J. J. Ferretti K. S. Gilmore P. Courvalin Nucleotide sequence analysis of the gene specifying the bifunctional 6′-aminoglycoside acetyltransferase 2′′-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities J. Bacteriol. 1986 167 631 638
55. R. Benveniste J. Davies Mechanism of antibiotic resistance in bacteria Annu. Rev. Biochem. 1973 42 471 506
56. T. J. Foster Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria Microbiol. Rev. 1983 47 361 409
57. A. M. Lovering L. O. White D. S. Reevew AAC(1): a new aminoglycoside-acetylating enzyme modifying the C1 aminogroup of apramycin J. Antimicrob. Chemother. 1987 20 803 813
58. S. Mitsuhashi, L. Rosival and V. Krcmery, Drug inactivating enzymes and antibiotic resistance, Springer-Verlag KG, Berlin, 1975, pp. 115-119
59. G. S. Gray W. M. Fitch Evolution of antibiotic resistance genes: the DNA sequence of a kanamycin resistance gene from Staphylococcus aureus Mol. Biol. Evol. 1983 1 1 57 66
60. D. H. Fong A. M. Berghuis Substrate promiscuiting of an aminoglycoside antibiotic resistance enzyme via target mimicry EMBO J. 2002 21 2323 2331
61. P. R. Thompson D. D. Boehr A. M. Berghuis G. D. Wright Mechanism of Aminoglycoside Antibiotic Kinase APH(3′)-IIIa: Role of the Nucleotide Positioning Loop Biochemistry 2002 41 22 7001 7007
62. K. Shi A. M. Berghuis Structural basis for dual nucleotide selectivity of aminoglycoside 2′′-phosphotransferase IVa provides insight on determinants of nucleotide specificity of aminoglycoside kinases J. Biol. Chem. 2012 287 16 13094 13102
63. A. van Broekhoven, F. Shapiro and J. Anné, Novel frontiers in the production of compounds for biomedical use, ed., M. Hofman, and, J. Anné, Kluwer Academic Publishers, Dordrecht, The Netherlands, 1st edn, 2001, pp. 87-96
64. R. G. Wax, K. Lewis, A. A. Salyers and H. Taber, Bacterial resistance to antimicrobials, ed., R. G. Wax, K. Lewis, A. A. Salyers, and, H. Taber, CRC Press, Boca Raton, 1st edn, 2001, pp. 106-114
65. J. C. Davies Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence Paediatr. Respir. Rev. 2002 3 2 128 134
66. J. E. Van Pelt R. Iyengar P. A. Frey Gentamicin nucleotidyltransferase. Stereochemical inversion at phosphorus in enzymatic 2′-deoxyadenylyl transfer to tobramycin J. Biol. Chem. 1986 261 15995 15999
67. S. Salian T. Matt R. Akbergenov S. Harish M. Meyer S. Duscha et al., Structure-Activity relationships among the kanamycin aminoglycosides: role of ring I hydroxyl and amino groups Antimicrob. Agents Chemother. 2012 56 12 6104 6108
68. M. D. Disney Studying modification of aminoglycoside antibiotics by resistance-causing enzymes vis microarray Methods Mol. Biol. 2012 808 303 320
69. G. A. McKay P. R. Thompson G. D. Wright Broad spectrum aminoglycoside phosphotransferase type III from Enterococcus: overexpression, purification, and substrate specificity Biochemistry 1994 33 6936 6944
70. P. R. Thompson D. W. Hughes G. D. Wright Regiospecificity of aminoglycoside phosphotransferase from Enterococci and Staphylococci (APH(3′)-IIIa) Biochemistry 1996 35 8686 8695
71. A. D. W. Boran R. Iyengar Systems approaches to polypharmacology and drug discovery Curr. Opin. Drug Discovery Dev. 2010 13 297 309
72. M. A. Yildirim K. I. Goh M. E. Cusick A. L. Barabási M. Vidal Drug-target network Nat. Biotechnol. 2007 25 10 1119 1126
73. S. J. Caldwell A. M. Berghuis Small-angle X-ray scattering analysis of the bifunctional antibiotic resistance enzyme aminoglycoside (6′) acetyltransferase-ie/aminoglycoside (2′′) phosphotransferase-ia reveals a rigid solution structure Antimicrob. Agents Chemother. 2012 56 4 1899 1906
74. W. Li J. Li Q. Wei Q. Hu X. Lin M. Chen et al., Characterization of aminoglycoside resistance and virulence genes among Enterococcus spp. isolated from a hospital in China Int. J. Environ. Res. Public Health 2015 12 3 3014 3025
75. E. Padmasini R. Padmaraj S. S. Ramesh High level aminoglycoside resistance and distribution of aminoglycoside resistant genes among clinical isolates of Enterococcus species in Chennai, India Sci. World J. 2014 2014 329157
76. J. M. Munita A. S. Bayer C. A. Arias Evolving Resistance Among Gram-positive Pathogens Clin. Infect. Dis. 2015 61 Suppl 2 S48 57
77. P. M. Mira J. C. Meza A. Nandipati M. Barlow Adaptive landscapes of resistance genes change as antibiotic concentrations change Mol. Biol. Evol. 2015 32 10 2707 2715
78. J. Sakon H. H. Liao A. M. Kanikula M. M. Benning I. Rayment H. M. Holden Molecular structure of kanamycin nucleotidyltransferase determined to 3.0 A resolution Biochemistry 1993 32 11977 11984
79. L. E. Wybenga-Groot K. Draker G. D. Wright A. M. Berghuis Crystal structure of an aminoglycoside 6′-N-acetyltransferase: defining the GCN5-related N-acetyltransferase superfamily fold Structure 1999 7 497 507
80. J. M. Gajer S. D. Furdas A. Gründer M. Gothwal U. Heinicke K. Keller et al., Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo Oncogenesis 2015 4 e137
81. F. Manzo F. P. Tambaro A. Mai L. Altucci Histone acetyltransferase inhibitors and preclinical studies Expert Opin. Ther. Pat. 2009 19 6 761 774
82. W.-C. Hon G. A. McKay P. R. Thompson R. M. Sweet D. S. C. Yang G. D. Wright et al., Structure of an Enzyme required for aminoglycoside antibiotic resistance reveals homology to eukaryotic protein kinases Cell 1997 89 887 895
83. D. M. Daigle G. A. McKay G. D. Wright Inhibition of aminoglycoside antibiotic resistance enzymes by protein kinase inhibitors J. Mol. Biol. 1997 272 24755 24758
84. H. Hidaka M. Inagaki S. Kawamoto Y. Sasaki Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C Biochemistry 1984 23 5036 5041
85. L. Aravind E. V. Koonin DNA polymerase beta-like nucleotidyltransferase superfamily: Identification of three new families, classification and evolutionary history Nucleic Acids Res. 1999 27 7 1609 1618
86. Z. Gao D. J. Maloney L. M. Dedkova S. M. Hecht Inhibitors of DNA polymerase beta: activity and mechanism Bioorg. Med. Chem. 2008 16 8 4331 4340
87. K. H. Barakat M. M. Gajewski J. A. Tuszynski DNA polymerase beta (pol β) inhibitors: a comprehensive overview Drug Discovery Today 2012 17 913 920
88. J. L. Hansen P. B. Moore T. A. Steitz Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit J. Mol. Biol. 2003 330 5 1061 1075
89. M. J. Cabanas D. Vazquez J. Modolell Inhibition of ribosomal translocation by aminoglycoside antibiotics Biochem. Biophys. Res. Commun. 1978 83 991 997
90. B. Francois R. J. M. Russel J. B. Murray F. Aboul-ela B. Masquida Q. Vicens et al., Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding Nucleic Acids Res. 2005 33 5677 5690
91. M. W. Vetting S. S. Hedge F. Javid-Majd J. S. Blanchard S. L. Roderick Aminoglycoside 2′-N-acetyltransferase from Mycobacterium tuberculosis in complex with coenzyme A and aminoglycoside substrates Nat. Struct. Biol. 2002 9 653 658
92. G. Cox P. J. Stogios A. Savchenko G. D. Wright Structural and Molecular Basis for Resistance to Aminoglycoside Antibiotics by the Adenylyltransferase ANT(2′′)-Ia mBio 2015 6 1 e02180
93. J. Kondo B. Francois R. J. Russell J. B. Murray E. Westof Crystal structure of the bacterial ribosomal decoding site complexed with amikacin containing the gamma-amino-alpha-hydroxybutyryl (haba) group Biochimie 2006 88 1027 1031
94. G. G. Zhanel C. D. Lawson S. Zelenitsky B. Findlay F. Schweizer H. Adam et al., Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin Expert Rev. Anti-Infect. Ther. 2012 10 4 459 473
95. S. C. Olsen S. A. Carlson In vitro bactericidal activity of aminoglycosides, including the next-generation drug plazomicin, against Brucella spp Int. J. Antimicrob. Agents 2015 45 1 76 78
96. M. Bassetti E. Righi Development of novel antibacterial drugs to combat multiple resistant organisms Langenbecks Arch. Surg. 2015 400 2 153 165
97. M. Bassetti E. Righi New antibiotics and antimicrobial combination therapy for the treatment of Gram-negative bacterial infections Curr. Opin. Crit. Care 2015 21 5 402 411
98. E. Bettiol S. Harbarth Development of new antibiotics: taking off finally? Swiss Med. Wkly. 2015 145 w14167
99. E. S. Armstrong G. H. Miller Combating evolution with intelligent design: the neoglycoside ACHN-490 Curr. Opin. Microbiol. 2010 13 5 565 573
100. G. D. Wrights The antibiotic resistome: the nexus of chemical and genetic diversity Nat. Rev. Microbiol. 2007 5 175 186
101. S. M. Hatosy A. C. Martiny The ocean as a global reservoir of antibiotic resistance genes Appl. Environ. Microbiol. 2015 81 21 7593 7599
102. B. Becker M. A. Cooper Aminoglycoside antibiotics in the 21st century ACS Chem. Biol. 2013 8 1 105 115
103. G. D. Wright P. Ladak Overexpression and characterization of the chromosomal aminoglycoside 6′-N-acetyltransferase from Enterococcus faecium Antimicrob. Agents Chemother. 1997 41 5 956 960
104. D. H. Fong A. M. Berghuis Structural basis of APH(3′)-IIIa-mediated resistance to N1-substituted aminoglycoside antibiotics Antimicrob. Agents Chemother. 2009 53 3049 3055